Dexter Susan - Insider Non-Derivative Transactions at Sonnet BioTherapeutics Holdings, Inc. (SONN) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 2, 2025, Dexter Susan's relationship to Sonnet BioTherapeutics Holdings, Inc. (SONN) is Director, and currently has 0 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other SONN insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Dexter Susan - Insider Non-Derivative Transactions of SONN Common Stock

Dexter Susan - Insider Non-Derivative Transactions at SONN

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 3, 2025	Disposition -- (Common Stock)	9643	0	0
Jul 12, 2025	Acquisition -- (Common Stock)	8000	0	9643
Dec 12, 2023	Acquisition -- (Common Stock)	1452	0	1643
Jun 15, 2023	P -- (Common Stock)	10000	0.7	33667
Jan 8, 2023	Disposition -- (Common Stock)	14627	0	9040
Jan 8, 2023	Acquisition -- (Common Stock)	14627	0	23667